1 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
[11] D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 [7] ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 [1] 226 💬 |
2 |
A-dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
3 |
Alkalinized lidocaine-heparin |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
4 |
Behavioral: role of dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
5 |
Bladder instillation with heparin/ lidocaine |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
6 |
Bromocriptine and other dopamine agonists |
Bromocriptine |
[4] D00633 D00633, D00780 D00780, D03165 D03165, D07870 D07870 💬 |
DRD1 [6] DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 |
Alcoholism [15] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
7 |
Bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 [8] 46, 51, 53, 70, 96, 168, 226, 298 💬 |
8 |
Bupivacaine hydrochloride |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 [2] 46, 53 💬 |
9 |
Bupivacaine hydrochloride 0.5% (marcaine, pfizer) |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 [1] 46 💬 |
10 |
Bupivacaine injection 0.5% |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
168 [1] 168 💬 |
11 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
[14] D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
12 |
Ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
13 |
Ceftazidime and tobramycin |
Ceftazidime |
[4] D00063 D00063, D00921 D00921, D02542 D02542, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
14 |
Ceftazidime pentahydrate |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
15 |
Ceftazidime/avibactam |
Avibactam |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
16 |
Ceftriaxone |
Ceftriaxone |
[2] D00924 D00924, D07659 D07659 💬 |
- |
- |
002 [3] 2 , 6 , 97 💬 |
17 |
Cefuroxime |
Cefuroxime |
[4] D00262 D00262, D00914 D00914, D00915 D00915, D03431 D03431 💬 |
- |
- |
097 [2] 97, 299 💬 |
18 |
Cerebral dopamine neurotrophic factor |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
19 |
Clindamycin |
Clindamycin |
[4] D00277 D00277, D01073 D01073, D01990 D01990, D02132 D02132 💬 |
- |
- |
046 [2] 46, 299 💬 |
20 |
Conivaptan |
Conivaptan |
[2] D01236 D01236, D07748 D07748 💬 |
AVPR1A [2] AVPR1A, AVPR2 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
21 |
Continuous infusion ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
22 |
Continuous release dopamine agonists |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
23 |
Dextrose |
Dextrose, unspecified form |
- |
- |
- |
056 [4] 56, 60, 65, 70 💬 |
24 |
Dextrose, 5% in water |
Dextrose, unspecified form |
[1] D00001 D00001 💬 |
- |
- |
065 [1] 65 💬 |
25 |
Dobutamine |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 [3] 57, 58, 215 💬 |
26 |
Dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 7 , 74 💬 |
27 |
Dopamine agent |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
28 |
Dopamine agonist treatment |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
074 [1] 74 💬 |
29 |
Dopamine agonists |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
074 [1] 74 💬 |
30 |
Dopamine agonists (pramipexole, ropirinole) |
Dopamine |
[4] D00559 D00559, D00633 D00633, D05575 D05575, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
31 |
Ercp with bupivacaine infusion |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
298 [1] 298 💬 |
32 |
Heparin & alkalinized lidocaine bladder instillation |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
33 |
Intermittent, short infusion ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
34 |
Iv ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
35 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
36 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
37 |
Lidocaine 1% injectable solution |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
034 [1] 34 💬 |
38 |
Lidocaine 2% without vessel constrictor |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [1] 51 💬 |
39 |
Lidocaine injection 2% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
168 [1] 168 💬 |
40 |
Lidocaine patch 5% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
41 |
Lidocaine releasing intravesical system - liris® |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
42 |
Liposomal bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [3] 51, 70, 96 💬 |
43 |
Local anesthesia (lidocaine hydrochloride) |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
44 |
Magnesium sulfate |
Magnesium |
[1] D01108 D01108 💬 |
- |
- |
011 [3] 11, 296, 297 💬 |
45 |
Nitroglycerin |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
46 |
Nitroglycerin ointment 2% |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
47 |
Other: dextrose water 5% |
Dextrose, unspecified form |
[1] D00001 D00001 💬 |
- |
- |
056 [1] 56 💬 |
48 |
Other: dobutamine |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
49 |
Procedure: embryonic dopamine cell implant surgery |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
50 |
Prolotherapy solution of 20% dextrose |
Dextrose, unspecified form |
- |
- |
- |
070 [1] 70 💬 |
51 |
Recombinant human cerebral dopamine neurotrophic factor |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
52 |
Spironolactone and conivaptan |
Conivaptan |
[3] D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A [3] AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
53 |
Topical amphimatrix with nitroglycerin (mqx-503) |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
54 |
Topical organogel with nitroglycerin |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
55 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |